Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach

Journal of Proteome Research

Volumn 5, Issue 10, 2006, Pages 2769-2779

  Pan, Sheng ^b   Wang, Yan ^a   Quinn, Joseph F ^c   Peskind, Elaine R ^a,d   Waichunas, Dana ^c   Wimberger, Jake T ^a   Jin, Jinghua ^a   Li, Jane G ^a   Zhu, David ^a   Pan, Catherine ^a   Zhang, Jing ^a,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebrospinal fluid; Glycoprotein; Hydrazide chemistry; Lectin affinity column; Mass spectrometry; Proteomics

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN; LECTIN;

ADULT; ARTICLE; BODY FLUID; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CHROMATOGRAPHY; DATA BASE; DEGENERATIVE DISEASE; DISEASE COURSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MONITORING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEOMICS; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; GLYCOPROTEINS; HUMANS; HYDRAZINES; LECTINS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS;

EID: 33750130282     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr060251s     Document Type: Article

References (38)

1. Wood, J. H. Physiology, Pharmacology, and Dynamics of Cerebrospinal Fluid; Plenum: New York, 1980; Vol. 1.
2. Milhorat, T. H. Cerebrospinal fluid as a reflection of internal milieu of brain. In Neurobiology of Cerebrospinal Fluid; Wood, J. H., Ed.; Plenum: New York, 1983; Vol. 2.
3. Verbeek, M. M.; De Jong, D.; Kremer, H. P., Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases. Ann. Clin. Biochem. 2003, 40, (Pt 1), 25-40.
4. Aebersold, R.; Mann, M., Mass spectrometry-based proteomics. Nature 2003, 422 (6928), 198-207.
5. Aebersold, R.; Anderson, L.; Caprioli, R.; Druker, B.; Hartwell, L.; Smith, R. Perspective: a program to improve protein biomarker discovery for cancer. J. Proteome Res. 2005, 4 (4), 1104-1109.
6. Zhang, J.; Goodlett, D.; Montine, T. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. J. Alzheimer's Dis. 2005, 8 (4), 377-386.
7. Blennow, K. CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment. Exp. Rev. Mol. Diagn. 2005, 5 (5), 661-672.
8. Montine, T. J.; Quinn, J. F.; Montine, K. S.; Kaye, J. A.; Breitner, J. C. Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease. J. Alzheimer's Dis. 2005, 8 (4), 359-367.
9. Xu, J.; Chen, J.; Peskind, E.; Jin, J.; Eng, J.; Pan, C.; Montine, T.; Goodlett, D.; Zhang, J. Characterization of proteome of human cerebrospinal fluid. Int. Rev. Neurobiol. 2006, 73, 29-98.
10. Sickmann, A.; Dormeyer, W.; Wortelkamp, S.; Woitalla, D.; Kuhn, W.; Meyer, H. E. Towards a high-resolution separation of human cerebrospinal fluid. J. Chromatogr., B Anal. Technol Biomed. Life Sci. 2002, 771 (1-2), 167-196.
11. Blennow, K.; Fredman, P.; Wallin, A.; Gottfries, C. G.; Karlsson, I.; Langstrom, G.; Skoog, I.; Svennerholm, L.; Wikkelso, C. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur. Neurol. 1993, 33 (2), 129-133.
12. Anderson, N. L; Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1 (11), 845-867.
13. Abdi, F.; Quinn, J. F.; Jankovic, J.; McIntosh, M.; Leverenz, A. B.; Peskind, E.; Nixon, R.; Nutt, J.; Chung, K.; Zabetian, C.; Samii, A.; Lin, M.; Hattan, S.; Pan, C.; Wang, Y.; Jin, J.; Zhu, D.; Li, J. Y.; Liu, Y.; Waichunas, D.; Montine, T. J.; Zhang, J. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J. Alzheimer's Dis. 2006, 9 (3), 293-348.
14. Zhang, J.; Goodlett, D. R.; Quinn, J. F.; Peskind, E.; Kaye, J. A.; Zhou, Y.; Pan, C.; Yi, E.; Eng, J.; Wang, Q.; Aebersold, R. H.; Montine, T. J. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J. Alzheimer's Dis. 2005, 7 (2), 125-133.
15. Zhang, J.; Goodlett, D. R.; Peskind, E. R.; Quinn, J. F.; Zhou, Y.; Wang, Q.; Pan, C.; Yi, E.; Eng, J.; Aebersold, R. H.; Montine, T. J. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiol. Aging 2005, 26 (2), 207-227.
16. Gronborg, M.; Kristiansen, T. Z.; Stensballe, A.; Andersen, J. S.; Ohara, O.; Mann, M.; Jensen, O. N.; Pandey, A. A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol. Cell. Proteomics 2002, 1 (7), 517-527.
17. Yang, Z.; Hancock, W. S. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J. Chromatogr., A 2004, 1053 (1-2), 79-88.
18. Liu, T.; Qian, W. J.; Gritsenko, M. A.; Camp, D. G., II; Monroe, M. E.; Moore, R. J.; Smith, R. D. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J. Proteome Res. 2005, 4 (6), 2070-2080.
19. Yang, Z.; Hancock, W. S.; Chew, T. R.; Bonilla, L. A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS. Proteomics 2005, 5 (13), 3353-3366.
20. Bause, E. Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes. Biochem. J. 1983, 209 (2), 331-336.
21. Roth, J. Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem. Rev. 2002, 102 (2), 285-303.
22. Spiro, R. G. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 2002, 12 (4), 43R-56R.
23. Freeze, H. H. Update and perspectives on congenital disorders of glycosylation. Glycobiology 2001, 11 (12), 129R-143R.
24. Durand, G.; Seta, N. Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin. Chem. 2000, 46 (6 Pt 1), 795-805.
25. Kaji, H.; Saito, H.; Yamauchi, Y.; Shinkawa, T.; Taoka, M.; Hirabayashi, J.; Kasai, K.; Takahashi, N.; Isobe, T. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat. Biotechnol. 2003, 21 (6), 667-672.
26. Geng, M.; Zhang, X.; Bina, M.; Regnier, F. Proteomics of glycoproteins based on affinity selection of glycopeptides from tryptic digests. J. Chromatogr., B Biomed. Sci. Appl. 2001, 752 (2), 293-306.
27. Zhang, H.; Li, X. J.; Martin, D. B.; Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21 (6), 660-666.
28. Folstein, M. F.; Folstein, S. E.; McHugh, P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12 (3), 189-198.
29. Reitan, R. Validity of the Trail-Making Test as an indication of organic brain damage. Percept. Mot. Skills 1958, 8, 271-276.
30. Morris, J. C. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr. 1997, 9 (Suppl. 1), 173-176; discussion 177-178.
31. Mattis, S.; Coblentz, J. Mental Status Examination for Organic Mental Syndrome in the Elderly Patient. Grune and Stratton: New York, 1976; p 77-121.
32. Flicker, C.; Ferris, S. H.; Reisberg, B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991, 41 (7), 1006-1009.
33. Blennow, K.; Fredman, P.; Wallin, A.; Gottfries, C. G.; Langstrom, G.; Svennerholm, L. Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio. Eur. Neurol. 1993, 33 (2), 126-128.
34. Blennow, K.; Fredman, P.; Wallin, A.; Gottfries, C. G.; Skoog, I.; Wikkelso, C.; Svennerholm, L. Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production. Eur. Neurol. 1993, 33 (2), 134-142.
35. Gatlin, C. L.; Eng, J. K.; Cross, S. T.; Detter, J. C.; Yates, J. R., III. Automated identification of amino acid sequence variations in proteins by HPLC/microspray tandem mass spectrometry. Anal. Chem. 2000, 72 (4), 757-763.
36. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74 (20), 5383-5392.
37. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75 (17), 4646-4658.
38. Wilkins, M. R.; Appel, R. D.; Van Eyk, J. E.; Chung, M. C.; Gorg, A.; Hecker, M.; Huber, L. A.; Langen, H.; Link, A. J.; Paik, Y. K.; Patterson, S. D.; Pennington, S. R.; Rabilloud, T.; Simpson, R. J.; Weiss, W.; Dunn, M. J. Guidelines for the next 10 years of proteomics. Proteomics 2006, 6 (1), 4-8.